HKUMed researchers (IMAGE)

The University of Hong Kong

HKUMed researchers

Caption

The HKUMed researchers have identified that liver cancer cells rely on the mevalonate pathway to shield themselves from programmed cell death. By blocking this pathway with atorvastatin, their key defenses could be effectively removed.

Credit

The University of Hong Kong

Usage Restrictions

N/A

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.